Association between Serum 25-hydroxy Vitamin D and Microalbuminuria in Overweight or Obese Male Patients with Type 2 Diabetes
Department of Endocrinology,Affiliated Hospital of Zunyi Medical University,Zunyi 563000,China
*Corresponding author:GAO Lin,Professor,Chief physician;E-mail:lgzymc@sina.com
GUO Jiuchang,ZHANG Lin,YANG Dan, et al. Association between Serum 25-hydroxy Vitamin D and Microalbuminuria in Overweight or Obese Male Patients with Type 2 Diabetes [J]. Chinese General Practice, 2020, 23(15): 1884-1888. DOI: 10.12114/j.issn.1007-9572.2020.00.229.
郭久畅,张琳,杨丹等. 超重或肥胖男性2型糖尿病患者血清25羟维生素D水平与微量白蛋白尿的相关性研究[J]. 中国全科医学, 2020, 23(15): 1884-1888. DOI: 10.12114/j.issn.1007-9572.2020.00.229.
[1]中华医学会内分泌学分会.中国2型糖尿病合并肥胖综合管理专家共识[J].中华内分泌代谢杂志,2016,32(8):623-627.DOI:10.3760/cma.j.issn.1000-6699.2016.08.001.
[2]中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014(11):792-801.
[3]DERAKHSHANIAN H,SHAB-BIDAR S,SPEAKMAN J R,et al.Vitamin D and diabetic nephropathy:a systematic review and meta-analysis[J].Nutrition,2015,31(10):1189-1194.DOI:10.1016/j.nut.2015.04.009.
[4]KRAMER H,REBOUSSIN D,BERTONI A G,et al.Obesity and albuminuria among adults with type 2 diabetes:the Look AHEAD(Action for Health in Diabetes) Study[J].Diabetes Care,2009,32(5):851-853.DOI:10.2337/dc08-2059.
[5]贾伟平.中国2型糖尿病防治指南(2017年版)[J].中华医学会糖尿病学分会,2017,10(1):4-67.DOI:10.3 760/cma.j.issn.1674-5809.2018.01.003.
[6]MITRI J,PITTAS A G.Vitamin D and diabetes[J].Endocrinol Metab Clin N Am,2014,43(1):205-232.DOI:10.1016/j.ecl.2013.09.010.
[7]ASANO L,WATANABE M,RYODEN Y,et al.Vitamin D metabolite,25-hydroxyvitamin D,regulates lipid metabolism by inducing degradation of SREBP/SCAP[J].Cell Chem Biol,2017,24(2):207-217.DOI:10.1016/j.chembiol.2016.12.017.
[8]MIRKOVIC K,VAN DEN BORN J,NAVIS G,et al.Vitamin D in chronic kidney disease:new potential for intervention[J].Curr Drug Targets,2011,12(1):42-53.DOI:10.2174/138945011793591572.
[9]TROHATOU O,TSILIBARY E F,CHARONIS A,et al.Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway[J].J Cell Mol Med,2017,21(10):2599-2609.DOI:10.1111/jcmm.13180.
[10]GUO J,LU C Q,ZHANG F X,et al.VDR activation reduces proteinuria and high-glucose-induced injury of kidneys and podocytes by regulating wnt signaling pathway[J].Cell Physiol Biochem,2017,43(1):39-51.DOI:10.1159/000480315.
[11]CUNNINGHAM J,LOCATELLI F,RODRIGUEZ M.Secondary hyperparathyroidism:pathogenesis,disease progression,and therapeutic options[J].Clin J Am Soc Nephrol,2011,6(4):913-921.DOI:10.2215/cjn.06040710.
[12]柳传威,洪秀韬,杨燕,等.2型糖尿病患者血清维生素D水平与代谢综合征的相关性研究[J].中华内分泌代谢杂志,2019,35(7):564-569.DOI:10.3760/cma.j.issn.1000-6699.2019.07.005.
[13]王雪,李英.维生素D延缓糖尿病肾病的研究进展[J].临床荟萃,2018,33(3):267-270.DOI:10.3969/j.issn.1004-583X.2018.03.020.
[14]DERAKHSHANIAN H,SHAB-BIDAR S,SPEAKMAN J R,et al.Vitamin D and diabetic nephropathy:a systematic review and meta-analysis[J].Nutrition,2015,31(10):1189-1194.DOI:10.1016/j.nut.2015.04.009.
[15]PEREIRA-SANTOS M,COSTA P R,ASSIS A M,et al.Obesity and vitamin D deficiency:a systematic review and meta-analysis[J].Obes Rev,2015,16(4):341-349.DOI:10.1111/obr.12239.
[16]SACERDOTE A,DAVE P,LOKSHIN V,et al.Type 2 diabetes mellitus,insulin resistance,and vitamin D[J].Curr Diab Rep,2019,19(10):101.DOI:10.1007/s11892-019-1201-y.
[17]李文和,张丽娟,胡译方,等.2型糖尿病患者血清25羟基维生素D与糖尿病肾脏疾病的相关性研究[J].中国糖尿病杂志,2018,26(5):402-406.DOI:10.3969/j.issn.1006-6187.2018.05.011.
[18]ANDRéSDóTTIR G,JENSEN M L,CARSTENSEN B,et al.Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors[J].Diabetes Care,2014,37(6):1660-1667.DOI:10.2337/dc13-2036.